Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan I Silverberg

Showing results (331-340 of 667) with videos related to

Pageof 67
Sort By:
American Journal of Clinical Dermatology|October 26, 2021
Expert Perspectives on Key Parameters that Impact Interpretation of Randomized Clinical Trials in Moderate-to-Severe Atopic DermatitisJonathan I Silverberg, Eric L Simpson, April W Armstrong, et al.
Journal of the American Academy of Dermatology|October 22, 2023
Safety and efficacy of eblasakimab, an interleukin 13 receptor α1 monoclonal antibody, in adults with moderate-to-severe atopic dermatitis: A phase 1b, multiple-ascending dose studyKaren A Veverka, Steven T G Thng, Jonathan I Silverberg, et al.
Dermatology and Therapy|April 30, 2021
Risk of Venous Thromboembolism Among Patients with Atopic Dermatitis: A Cohort Study in a US Administrative Claims DatabaseKristin J Meyers, Jonathan I Silverberg, Maria Jose Rueda, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|March 28, 2023
The (one-year) prevalence of atopic dermatitis in Brazil: A population-based telephone surveyHélio Amante Miot, Valeria Aoki, Raquel Leão Orfali, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|July 17, 2022
Patient-oriented measures for phase 3 studies of tralokinumab for the treatment of atopic dermatitis (ECZTRA 1, 2, and 3)Eric L Simpson, Andreas Wollenberg, Weily Soong, et al.
Archives of Dermatological Research|November 22, 2020
What are the highest yielding search strategy terms for systematic reviews in atopic dermatitis? A systematic reviewMarissa T Ayasse, Adnan Ahmed, Maria L Espinosa, et al.
The Journal of Investigative Dermatology|August 5, 2021
Differences in Psychometric Properties of Clinician- and Patient-Reported Outcome Measures for Atopic Dermatitis by Race and Skin Tone: A Systematic ReviewTrisha Kaundinya, Uros Rakita, Armaan Guraya, et al.
Dermatitis : Contact, Atopic, Occupational, Drug|September 21, 2018
Sleep Disturbance and Sleep-Related Impairment in Adults With Atopic Dermatitis: A Cross-sectional StudyJennifer C Li, Anna Fishbein, Vivek Singam, et al.
Paediatric Drugs|March 16, 2022
Subgroup Analysis of Crisaborole for Mild-to-Moderate Atopic Dermatitis in Children Aged 2 to < 18 YearsThomas A Luger, Adelaide A Hebert, Andrea L Zaenglein, et al.
Journal of Patient-Reported Outcomes|July 15, 2024
Capturing patient-reported sleep disturbance in atopic dermatitis clinical trialsCarla Dias-Barbosa, Jonathan I Silverberg, Sonja Ständer, et al.
Pageof 67

Showing results (331-340 of 667) with videos related to

Sort By:
Pageof 67
American Journal of Clinical Dermatology|October 26, 2021
Expert Perspectives on Key Parameters that Impact Interpretation of Randomized Clinical Trials in Moderate-to-Severe Atopic DermatitisJonathan I Silverberg, Eric L Simpson, April W Armstrong, et al.
Journal of the American Academy of Dermatology|October 22, 2023
Safety and efficacy of eblasakimab, an interleukin 13 receptor α1 monoclonal antibody, in adults with moderate-to-severe atopic dermatitis: A phase 1b, multiple-ascending dose studyKaren A Veverka, Steven T G Thng, Jonathan I Silverberg, et al.
Dermatology and Therapy|April 30, 2021
Risk of Venous Thromboembolism Among Patients with Atopic Dermatitis: A Cohort Study in a US Administrative Claims DatabaseKristin J Meyers, Jonathan I Silverberg, Maria Jose Rueda, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|March 28, 2023
The (one-year) prevalence of atopic dermatitis in Brazil: A population-based telephone surveyHélio Amante Miot, Valeria Aoki, Raquel Leão Orfali, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|July 17, 2022
Patient-oriented measures for phase 3 studies of tralokinumab for the treatment of atopic dermatitis (ECZTRA 1, 2, and 3)Eric L Simpson, Andreas Wollenberg, Weily Soong, et al.
Archives of Dermatological Research|November 22, 2020
What are the highest yielding search strategy terms for systematic reviews in atopic dermatitis? A systematic reviewMarissa T Ayasse, Adnan Ahmed, Maria L Espinosa, et al.
The Journal of Investigative Dermatology|August 5, 2021
Differences in Psychometric Properties of Clinician- and Patient-Reported Outcome Measures for Atopic Dermatitis by Race and Skin Tone: A Systematic ReviewTrisha Kaundinya, Uros Rakita, Armaan Guraya, et al.
Dermatitis : Contact, Atopic, Occupational, Drug|September 21, 2018
Sleep Disturbance and Sleep-Related Impairment in Adults With Atopic Dermatitis: A Cross-sectional StudyJennifer C Li, Anna Fishbein, Vivek Singam, et al.
Paediatric Drugs|March 16, 2022
Subgroup Analysis of Crisaborole for Mild-to-Moderate Atopic Dermatitis in Children Aged 2 to < 18 YearsThomas A Luger, Adelaide A Hebert, Andrea L Zaenglein, et al.
Journal of Patient-Reported Outcomes|July 15, 2024
Capturing patient-reported sleep disturbance in atopic dermatitis clinical trialsCarla Dias-Barbosa, Jonathan I Silverberg, Sonja Ständer, et al.
Pageof 67